By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Additional Positive Data from Phase 1 MAD Study of DA-1726 in Obesity On April 22, 2025, MetaVia Inc. (NASDAQ:MTVA) announced additional positive topline results from the multiple ascending dose (MAD) Part 2 of the Phase 1 clinical trial of DA-1726 in obesity. … Read more
Brown, Goldstein & Levy attorney Monica Basche was quoted in a recent Baltimore Sun article that reported on the Maryland Department of Public Safety and Correctional Services (“DPSCS”) pilot program for body-worm cameras for correctional officers. The pilot program will start with a staggered roll-out at five Maryland prisons, with an agency-wide roll-out later this … Read more
By Thomas Kerr, CFA NASDAQ:USEG READ THE FULL USEG RESEARCH REPORT On January 10, 2025, U.S. Energy (NASDAQ:USEG) announced it had closed on the acquisition of additional helium acreage in the Kevin Dome structure where it currently operates. The deal includes an 80% interest in 24,000 acres owned by Synergy Offshore (“SOG”). This deal was … Read more
By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT FDA Response to 510(k) Filing On October 6, 2024, Monogram (NASDAQ:MGRM) announced it had received an Additional Information Request (“AIR”) from the U.S. Food and Drug Administration (“FDA”) on September 30, 2024, regarding its 510(k) premarket filing submission for the semi-active mBôs TKA System. … Read more
Image by yousafbhutta from Pixabay On 26 September 2024, the Belgian Constitutional Court referred a highly topical issue of fair remuneration of authors and performers on online streaming platforms to the Court of Justice of the EU (CJEU). The reference, which is poised to result in one of the most significant CJEU judgments in the … Read more